Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07868835 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is one of two planned Phase 3 studies to support the weight management indication for VK2735 Oral in obese (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27kg/m2) adults with at least one weight-related comorbidity without type 2 diabetes mellitus.
Trial Details
NCT Number NCT07868835
Lead Sponsor Viking Therapeutics, Inc.
Conditions
(from sponsor)		 Weight Loss
Related terms Body Weight, Body Weight Changes, Weight Loss
Enrollment 560 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov